The Lupus Research Alliance applauds the decision by the U.S. Food and Drug Administration (FDA) to grant Breakthrough Therapy designation for litifilimab (BIIB059) in clinical development by Biogen ...

Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed improvements in cutaneous ...

This autoimmune disease may impact your skin as well as your nails and hair. Learn what to look for to treat lupus more effectively.

An international team, led by Paul R. Fortin of Université Laval, has just identified three markers that would allow for establishing, right at the time of diagnosis, the risk of a lupus ...

Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.

The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, according to a press release from manufacturer Biogen. Litifilimab (Biogen) is a ...

There are a few to keep in mind.

The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the ...

Lupus is a type of autoimmune disease. In an autoimmune disease, something goes wrong in the body’s immune system, causing it to harm healthy organs, tissues, and cells. “Auto” means “self” — so if ...

Kyleigh MacGregor plans her life five years at a time. MacGregor has lupus, an incurable disease in which her immune system attacks her body’s organs and tissue. It’s been a year since MacGregor, 31, ...

Today, the Lupus Research Alliance, the world's largest private funder of lupus research, announced the 2025 Global Team ...

Background The long-term trajectories of estimated glomerular filtration rate (eGFR) and their relation to early proteinuria ...